Lapatinib for Brain Metastases In ErbB2-Positive Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Neoplasms, Breast
Interventions: DRUG: lapatinib
Sponsor: Novartis Pharmaceuticals